Scarica l'app Stockscreener
0.3881
14.08%
0.0479
Dopo l'orario di chiusura:
.39
0.0019
+0.49%
Precedente Chiudi:
$0.3402
Aprire:
$0.331
Volume 24 ore:
1.26M
Relative Volume:
1.13
Capitalizzazione di mercato:
$46.10M
Reddito:
$436.97M
Utile/perdita netta:
$-35.62M
Rapporto P/E:
-1.301
EPS:
-0.2983
Flusso di cassa netto:
$-10.71M
1 W Prestazione:
+0.94%
1M Prestazione:
-32.80%
6M Prestazione:
-76.76%
1 anno Prestazione:
-78.32%
Intervallo 1D:
$0.331
$0.3881
Intervallo di 1 settimana:
$0.331
$0.4083
Portata 52W:
$0.3301
$2.10
Accuray Inc Stock (ARAY) Company Profile
Nome
Accuray Inc
Settore
Industria
Telefono
608-824-2800
Indirizzo
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.3881 | 40.41M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-13 | Iniziato | ROTH MKM | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Loop Capital | Buy |
| 2020-01-21 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-11-01 | Aggiornamento | Citigroup | Sell → Neutral |
| 2017-12-13 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Iniziato | Lake Street | Buy |
| 2016-12-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Iniziato | Citigroup | Sell |
| 2015-05-01 | Reiterato | Dougherty & Company | Buy |
| 2015-01-12 | Iniziato | Northland Capital | Outperform |
| 2014-01-31 | Reiterato | Dougherty & Company | Buy |
| 2014-01-29 | Reiterato | Brean Capital | Buy |
| 2013-11-11 | Reiterato | Dougherty & Company | Buy |
| 2013-08-29 | Reiterato | Dougherty & Company | Buy |
| 2011-09-20 | Reiterato | Ticonderoga | Buy |
| 2010-02-08 | Aggiornamento | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Aggiornamento | UBS | Sell → Neutral |
| 2009-03-09 | Downgrade | Soleil | Buy → Hold |
| 2009-01-30 | Aggiornamento | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Reiterato | Jefferies & Co | Hold |
| 2008-08-20 | Reiterato | Jefferies & Co | Hold |
Mostra tutto
Accuray Inc Borsa (ARAY) Ultime notizie
Portfolio Update: Can Accuray Incorporated stock outperform in a bear market2026 Market Sentiment & Safe Capital Allocation Plans - baoquankhu1.vn
Aug Reactions: Can Accuray Incorporated be recession proof2026 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn
Entry Recap: Whats the beta of Accuray Incorporated stock2026 Patterns & Long-Term Capital Growth Ideas - baoquankhu1.vn
Pharma News: Can Accuray Incorporated expand its profit margins2026 Market WrapUp & Reliable Breakout Forecasts - baoquankhu1.vn
Q1 2026 Accuray Inc Earnings Call Transcript - gurufocus.com
Vanguard (ARAY) amendment shows 0 shares after internal realignment - Stock Titan
Street Watch: Can Accuray Incorporated outperform in the next rallyTake Profit & Consistent Income Trade Ideas - baoquankhu1.vn
If You Invested $1,000 in Accuray Incorp (ARAY) - Stock Titan
ARAY SEC FilingsAccuray Incorp 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Retail: Can Accuray Incorporated expand its profit marginsQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Accuray (NASDAQ: ARAY) sets separation terms for chief commercial officer - Stock Titan
Layoff Watch: What are analysts price targets for Accuray IncorporatedQuarterly Portfolio Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Earnings Miss: Is Accuray Incorporated showing insider buyingMarket Activity Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Accuray Incorporated Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint
Trading Recap: Whats the beta of Accuray Incorporated stockJuly 2025 Institutional & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Book value per share of Accuray Incorporated – BX:XEJ - TradingView
Accuray (NASDAQ: ARAY) COO exercises RSUs, uses shares to cover tax - Stock Titan
[EFFECT] ACCURAY INC SEC Filing - Stock Titan
ARAY Technical Analysis & Stock Price Forecast - Intellectia AI
7.00M shares registered for resale as ARAY (NASDAQ: ARAY) lenders hold warrants - Stock Titan
Accuray Stock (ARAY) Opinions on Director Insider Purchase | ARAY Stock News - quiverquant.com
Can Accuray Incorporated expand its profit marginsMarket Volume Summary & Fast Moving Stock Trade Plans - baoquankhu1.vn
Aug Ideas: Can Accuray Incorporated expand its profit marginsMarket Volume Summary & Fast Moving Stock Trade Plans - baoquankhu1.vn
Whale Trades: Is Accuray Incorporated undervalued by DCF analysis - baoquankhu1.vn
Will Accuray Incorporated benefit from AI trendsWeekly Loss Report & Technical Confirmation Alerts - mfd.ru
Will Accuray Incorporated (XEJ) stock benefit from mergersWeekly Trend Report & Detailed Earnings Play Strategies - mfd.ru
Accuray Warned by Nasdaq Over Sub‑$1 Share Price, Faces Rising Delisting and Liquidity Risks - The Globe and Mail
Accuray Releases Updated Investor Presentation Under Regulation FD - The Globe and Mail
Accuray (ARAY) Plans to Sell 7 Million Shares of Common Stock - GuruFocus
Accuray (ARAY) files S-3 to register 7.0M warrant shares for lender resale - Stock Titan
ACCURAY INC SEC 10-Q Report - TradingView
Accuray posts updated investor presentation, to present to analysts and investors - TradingView
Accuray Incorporated : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Why is Accuray Incorporated stock going down2025 Technical Patterns & Technical Pattern Alert System - mfd.ru
Panic Selling: Is Accuray Incorporated benefiting from innovation trends2025 Fundamental Recap & Reliable Price Breakout Signals - baoquankhu1.vn
ARAY PE Ratio & Valuation, Is ARAY Overvalued - Intellectia AI
ARAY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Accuray Incorporated undervalued by DCF analysis2025 Top Gainers & Precise Entry and Exit Recommendations - mfd.ru
EPS Watch: Will Accuray Incorporated benefit from AI trendsQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Risk Report: Is Accuray Incorporated showing insider buyingTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
Aug Setups: Can Accuray Incorporated stock outperform in a bear market2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Accuray (NASDAQ:ARAY) Cut to "Sell" at Wall Street Zen - MarketBeat
Accuray receives Nasdaq notice for non-compliance with minimum bid price rule - Investing.com Canada
Accuray Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
The Market Doesn't Like What It Sees From Accuray Incorporated's (NASDAQ:ARAY) Revenues Yet As Shares Tumble 33% - simplywall.st
Accuray (ARAY) Analyst Rating Update: Price Target Cut by 50% | - GuruFocus
Accuray Incorporated (NASDAQ:ARAY) Q2 2026 Earnings Call Transcript - Insider Monkey
BTIG cuts Accuray stock price target to $2 from $4 on China volatility - Investing.com Canada
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Accuray: Fiscal Q2 Earnings Snapshot - theheraldreview.com
Accuray Q2 2026 Earnings Call Insights - Intellectia AI
Accuray Inc Azioni (ARAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Accuray Inc Azioni (ARAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):